Work

Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.2500.2500

Authors: Sonali M. Smith, Jeffrey L. Johnson, Donna Niedzwiecki, J. Paul Eder, George P. Canellos, Bruce D. Cheson, Nancy L. Bartlett

Institutions: University of Chicago, Duke University, Duke Medical Center, Dana-Farber Cancer Institute, Georgetown University, Georgetown Lombardi Comprehensive Cancer Center, Washington University in St. Louis

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2569488123

FWCI: 0.109

Cites:

Cited by: 1

Related to: 10